No beneficial effect of interferon-gamma treatment in 2 human immunodeficiency virus-infected patients with Mycobacterium avium complex infection.

F. N. Lauw*, J. T. van Der Meer, J. de Metz, S. A. Danner, T. van Der Poll

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


Two human immunodeficiency virus-infected patients with refractory disseminated Mycobacterium avium complex infection were treated with recombinant interferon-gamma (IFN-gamma) given subcutaneously for 3 and 4 months, respectively. Although both patients demonstrated some clinical improvement initially, IFN-gamma therapy did not produce sustained benefit.

Original languageEnglish
Pages (from-to)e81-82
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America
Issue number4
Publication statusPublished - 15 Feb 2001

Cite this